Companies

ARS Pharmaceuticals, Inc. (SPRY) SEC filings

CIK 0001671858 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023FY2022
Revenue (USD)84.3 M300001.3 M
Net income (USD)-54.4 M-34.7 M-20.2 M
Diluted EPS (USD/shares)-1.74-0.57-0.87

Latest filings

FiledFormDescriptionPeriod
2026-10-19144144
2026-10-05442026-10-01
2026-10-01144144
2026-09-30144144
2026-09-11144144
2026-09-11144144
2026-09-04144144
2026-09-03144144
2026-09-02442026-09-01
2026-09-02144144
2026-09-01144144
2026-08-31144144
2026-08-20144144
2026-08-20144144
2026-08-19144144
2026-08-19144144
2026-08-18144144
2026-08-18144144
2026-08-17332026-08-17
2026-08-1310-Q10-Q2026-06-30
2026-08-138-K8-K items 2.02,9.012026-08-13
2026-07-27SCHEDULE 13GSCHEDULE 13G
2026-07-178-K8-K items 5.022026-07-15
2026-07-14SCHEDULE 13G/ASCHEDULE 13G/A
2026-07-078-K8-K items 5.022026-07-06

Forms on file (last 1,000): 4 230, 144 66, 8-K 66, 3 34, 10-Q 17, DEFA14A 11, SC 13G/A 10, CORRESP 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=SPRY (0.002 USD), /gw/filings/filings?ticker=SPRY&form=8-K, /gw/filings/facts?ticker=SPRY&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange